[Drug induced megaloblastic anemia].
D000748:Anemia, Macrocytic / Q000139:chemically induced*; D000749:Anemia, Megaloblastic / Q000139:chemically induced*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001379:Azathioprine / Q000009:adverse effects; D001853:Bone Marrow / Q000378:metabolism; D001854:Bone Marrow Cells; D004247:DNA / Q000378:metabolism; D005492:Folic Acid / Q000378:metabolism*; D005493:Folic Acid Antagonists / Q000009:adverse effects*; D006801:Humans; D015122:Mercaptopurine / Q000009:adverse effects; D008727:Methotrexate / Q000009:adverse effects; D011687:Purines / Q000037:antagonists & inhibitors*; D011739:Pyrimethamine / Q000009:adverse effects; D013762:Tetrahydrofolate Dehydrogenase / Q000378:metabolism; D013763:Tetrahydrofolates / Q000378:metabolism
D000970:Antineoplastic Agents; D005493:Folic Acid Antagonists; D011687:Purines; D013763:Tetrahydrofolates; D004247:DNA; D005492:Folic Acid; D015122:Mercaptopurine; D013762:Tetrahydrofolate Dehydrogenase; D001379:Azathioprine; D008727:Methotrexate; D011739:Pyrimethamine
Arzneimittelinduzierte megaloblastäre Anämien.